People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being Novo Nordisk today announced results from the US-based INFORM survey of people taking semaglutide for weight management…
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cat Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the…
WuXi Biologics Achieves “CDMO of the Year” Among Three Prestigious IMAPAC Awards WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received…
Cholera Deaths Rise for Second Year Despite Available Prevention and Treatment The World Health Organization (WHO) has published its global cholera statistics for 2024, showing an increase in both the number…
Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today celebrated 10 years of Surf Away+, an…
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Diagnostic Leadership with Enhanced Meningitis/Encephalitis Panel QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a significant regulatory milestone: the…
AGC Biologics Seattle Facility Celebrates Milestone Year with Regulatory Approvals, Quality Achievements, and Leadership Expansion AGC Biologics, a leading global contract development and manufacturing organization (CDMO), has announced that its…
Modeyso™ (Dordaviprone) Gains Inclusion in NCCN Clinical Practice Guidelines, Marking a Milestone in the Treatment of H3 K27M-Mutant Diffuse Glioma Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced a pivotal development for…
ScaleReady Awards G-Rex® Grants to Advance Cell and Gene Therapy Manufacturing Across California ScaleReady, a joint venture formed by Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, announced a…
Royalty Pharma and Deloitte Release Landmark Study on the Role of Royalties in Funding Biopharma Innovation Royalty Pharma plc (Nasdaq: RPRX), the world’s largest acquirer of biopharmaceutical royalties and a…
Novartis to Acquire Tourmaline Bio, Advancing Cardiovascular Pipeline with Pacibekitug for ASCVD Novartis today revealed a major step forward in its cardiovascular disease (CVD) strategy with the announcement that it…
BOTOX® Cosmetic Unveils “The One & Only” Campaign: A Celebration of Authenticity, Self-Expression, and Patient Stories A New Chapter for an Iconic Brand BOTOX® Cosmetic (onabotulinumtoxinA), one of the most…